Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

JP Drafts (November 2021)

JP drafts for public comments, November 1 - 30, 2021

Revised General Information

Note:
Please refer both Briefing Note[580KB] for General Tests and General Information related to Chromatography and 4 JP drafts that have been under public consultation since September.


To send the comment on these drafts, the guidance is as follows:

  1. Download the form for comments in Word format[67.0KB]
  2. Fill in the form
  3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
  4. Send it to the email address: JPdraft-eng[at]pmda.go.jp

Note:
For the purpose of security, this email address is partly incorrect. Please replace [at] with @ when sending an email.


Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.